Clinical Trials Browser

UNKNOWN × Interventional × Pemetrexed × Clear all

NCT04762459 2022-02-24

APEX

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT03636685 2018-08-17

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

Phase 1/2 Unknown

Adenocarcinoma, Carcinoma, Squamous Cell

NCT02829008 2016-07-12

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms